Suppr超能文献

瑞芬太尼及其他阿片类药物。

Remifentanil and other opioids.

作者信息

Servin F S, Billard V

机构信息

CHU Bichat Claude Bernard, Paris, France.

出版信息

Handb Exp Pharmacol. 2008(182):283-311. doi: 10.1007/978-3-540-74806-9_14.

Abstract

Most opioids used in anaesthesia are of the anilidopiperidine family, including fentanyl, alfentanil, sufentanil and remifentanil. While all share similar pharmacological properties, remifentanil, the newest one, is probably the most original, which is the reason this review focusses especially on this drug. Remifentanil is a potent mu-agonist that retains all the pharmacodynamic characteristics of its class (regarding analgesia, respiratory depression, muscle rigidity, nausea and vomiting, pruritus, etc.) but with a unique pharmacokinetic profile that combines a short onset and the fastest offset, independent of the infusion duration. Consequently, it offers a unique titratability when its effects need to be quickly achieved or suppressed, but it requires specific drug delivery schemes such as continuous infusion, target-controlled infusion and anticipated postoperative pain treatment. Kinetic differences between opioids used in anaesthesia and some clinical uses of remifentanil are reviewed in this chapter.

摘要

麻醉中使用的大多数阿片类药物属于苯胺基哌啶家族,包括芬太尼、阿芬太尼、舒芬太尼和瑞芬太尼。虽然它们都具有相似的药理特性,但最新的瑞芬太尼可能是最独特的,这就是本综述特别关注这种药物的原因。瑞芬太尼是一种强效μ受体激动剂,保留了该类药物的所有药效学特征(关于镇痛、呼吸抑制、肌肉强直、恶心和呕吐、瘙痒等),但其独特的药代动力学特征结合了起效迅速和作用消失最快的特点,且与输注持续时间无关。因此,当需要迅速达到或抑制其作用时,它具有独特的可滴定性,但它需要特定的给药方案,如持续输注、靶控输注和术后疼痛预治疗。本章将综述麻醉中使用的阿片类药物之间的动力学差异以及瑞芬太尼的一些临床应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验